Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Radiotherapy × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Prostatic Neoplasms 23 Glioblastoma 21 Squamous Cell Carcinoma of Head and Neck 18 Carcinoma, Non-Small-Cell Lung 17 Lung Neoplasms 14 Sarcoma 10 Head and Neck Neoplasms 10 Glioma 9 Brain Neoplasms 9 Rectal Neoplasms 8 Astrocytoma 8 Uterine Cervical Neoplasms 7 Neoplasms 7 Esophageal Neoplasms 6 Colorectal Neoplasms 5 Urinary Bladder Neoplasms 4 Pancreatic Neoplasms 4 Oropharyngeal Neoplasms 4 Oligodendroglioma 4 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Melanoma 4 Carcinoma, Squamous Cell 4 Small Cell Lung Carcinoma 3 Sarcoma, Ewing 3 Recurrence 3 Radiation Injuries 3 Lymphoma, Follicular 3 Lymphoma 3

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡